AIM: £3.42 (+0.14) | Nasdaq: $20.00 (-0.53)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
Innovation Platform
Overview
R&D Approach
Our Pipeline
Key Corporate Partnerships
Innovation News
Commercial Platform
Overview
Competitive Advantages
Prescription Drugs
Consumer Health
Main Products
Commercial Platform News
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Financial Results
Overview
Chairman's Statement
Financial Highlights
Financial Reports
SEC Filings
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
Innovation Platform
Overview
R&D Approach
Our Pipeline
Key Corporate Partnerships
Innovation News
Commercial Platform
Overview
Competitive Advantages
Prescription Drugs
Consumer Health
Main Products
Commercial Platform News
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Financial Results
Overview
Chairman's Statement
Financial Highlights
Financial Reports
SEC Filings
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
Shareholder Information
Chi-Med
| Shareholder Information
Share Price Chart
London AIM:HCM
£3.42
+0.14 | 19 Aug 2019 | 16:10
Nasdaq AIM:HCM
US$20.00
-0.53 | 19 Aug 2019 | 15:59
Major Shareholders
Directors and Significant Shareholders
Events, Circulars and Forms
2019 Half-Year Financial Results
2019-07-30
Morgan Stanley Annual China Summit 2019
2019-05-31
Macquarie Greater China Conference 2019
2019-05-16
Investor FAQs
Frequently asked questions about Chi-Med's UK and US share listings
Information for Shareholders
Share-related address & contact information
AIM Rule 26 Disclosures
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
Analyst Coverage
Bank of America Merrill Lynch
Canaccord Genuity
Deutsche Bank
Edison
HSBC
Panmure Gordon
Trinity Delta